Alkermes Encourages You To Learn More About Alcohol Use Disorder

Alcohol use disorder is a debilitating disease that impacts millions of people every day, and the stigma surrounding it prevents people from seeking help. This Alcohol Awareness Month, we encourage everyone to learn more. If you or someone you know is living with AUD, check out these available resources: https://bit.ly/3uXFt3L

About Alkermes

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com